Výsledky vyhledávání

Akademický článek

Directing the migration of serum-free, ex vivo -expanded Vγ9Vδ2 T cells.

Autor: Parwani KK; Cancer Biology Program, Graduate Division of Biological and Biomedical Sciences, Emory University, Atlanta, GA, United States.; Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA, United States., Branella GM; Cancer Biology Program, Graduate Division of Biological and Biomedical Sciences, Emory University, Atlanta, GA, United States.; Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA, United States., Burnham RE; Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA, United States., Burnham AJ; Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA, United States., Bustamante AYS; Cancer Biology Program, Graduate Division of Biological and Biomedical Sciences, Emory University, Atlanta, GA, United States.; Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA, United States., Foppiani EM; Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA, United States., Knight KA; Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA, United States., Petrich BG; Expression Therapeutics LLC, Tucker, GA, United States., Horwitz EM; Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA, United States., Doering CB; Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA, United States., Spencer HT; Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA, United States.

Publikováno v: Frontiers in immunology [Front Immunol] 2024 Feb 29; Vol. 15, pp. 1331322. Date of Electronic Publication: 2024 Feb 29 (Print Publication: 2024).

Zobrazit plný text záznamu

Akademický článek

Ligand-based targeting of c-kit using engineered γδ T cells as a strategy for treating acute myeloid leukemia.

Autor: Branella GM; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States.; Graduate Division of Biological and Biomedical Sciences, Laney Graduate School, Emory University, Atlanta, GA, United States.; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, United States., Lee JY; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States.; Graduate Division of Biological and Biomedical Sciences, Laney Graduate School, Emory University, Atlanta, GA, United States.; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, United States., Okalova J; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States.; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, United States.; Molecular Systems Pharmacology Program, Graduate Division of Biological and Biomedical Sciences, Laney Graduate School, Emory University, Atlanta, GA, United States., Parwani KK; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States.; Graduate Division of Biological and Biomedical Sciences, Laney Graduate School, Emory University, Atlanta, GA, United States.; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, United States., Alexander JS; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States.; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, United States., Arthuzo RF; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States.; Graduate Division of Biological and Biomedical Sciences, Laney Graduate School, Emory University, Atlanta, GA, United States.; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, United States., Fedanov A; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States.; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, United States., Yu B; Expression Therapeutics, Inc., Tucker, GA, United States., McCarty D; Expression Therapeutics, Inc., Tucker, GA, United States., Brown HC; Expression Therapeutics, Inc., Tucker, GA, United States., Chandrakasan S; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States.; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, United States., Petrich BG; Expression Therapeutics, Inc., Tucker, GA, United States., Doering CB; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States.; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, United States.; Molecular Systems Pharmacology Program, Graduate Division of Biological and Biomedical Sciences, Laney Graduate School, Emory University, Atlanta, GA, United States., Spencer HT; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, United States.; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, United States.; Molecular Systems Pharmacology Program, Graduate Division of Biological and Biomedical Sciences, Laney Graduate School, Emory University, Atlanta, GA, United States.

Publikováno v: Frontiers in immunology [Front Immunol] 2023 Nov 13; Vol. 14, pp. 1294555. Date of Electronic Publication: 2023 Nov 13 (Print Publication: 2023).

Zobrazit plný text záznamu

Akademický článek

Enhancing the effectiveness of γδ T cells by mRNA transfection of chimeric antigen receptors or bispecific T cell engagers.

Autor: Becker SA; Molecular and System Pharmacology Program, Graduate Division of Biological and Biomedical Sciences, Emory University, Atlanta, GA, USA., Petrich BG; Expression Therapeutics, Inc, Tucker, GA, USA., Yu B; Expression Therapeutics, Inc, Tucker, GA, USA., Knight KA; Molecular and System Pharmacology Program, Graduate Division of Biological and Biomedical Sciences, Emory University, Atlanta, GA, USA., Brown HC; Expression Therapeutics, Inc, Tucker, GA, USA., Raikar SS; Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA, USA., Doering CB; Molecular and System Pharmacology Program, Graduate Division of Biological and Biomedical Sciences, Emory University, Atlanta, GA, USA.; Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA, USA., Spencer HT; Molecular and System Pharmacology Program, Graduate Division of Biological and Biomedical Sciences, Emory University, Atlanta, GA, USA.; Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA, USA.

Publikováno v: Molecular therapy oncolytics [Mol Ther Oncolytics] 2023 May 22; Vol. 29, pp. 145-157. Date of Electronic Publication: 2023 May 22 (Print Publication: 2023).

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání